Live from the NIH registry
Studies recruiting near Salem right now
Top 25 of 112 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 750 participants sought
Oregon Oncology Specialists — Salem, Oregon (1.5 mi)
· Sponsor: Amgen
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Oncology Associates of Oregon, P.C. — Albany, Oregon (20.2 mi)
· Sponsor: Pfizer
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
Acute Kidney Injury
N/A
Interventional 339 participants sought
Samaritan Health — Corvallis, Oregon (27.4 mi)
· Sponsor: SeaStar Medical
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Salem, Oregon (1.5 mi)
· Sponsor: AstraZeneca
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
Gynecologic Cancers, Breast Cancer
Phase 1
Interventional 60 participants sought
Samaritan Pastega Regional Cancer Center — Corvallis, Oregon (27.4 mi)
· Sponsor: Oregon State University
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 450 participants sought
Corvallis Clinic PC Clinical Research Department — Corvallis, Oregon (27.4 mi)
· Sponsor: Novo Nordisk A/S
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: University of Rochester
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Salem Hospital — Salem, Oregon (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Corvallis, Oregon (27.4 mi)
· Sponsor: AstraZeneca
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Pancreatic Neoplasm
N/A
Observational 770 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: SWOG Cancer Research Network
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Phase 2
Interventional 26 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Retina Consultants, LLC — Salem, Oregon (1.5 mi)
· Sponsor: EyeBiotech Ltd.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 147 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi)
· Sponsor: National Cancer Institute (NCI)